These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 1560202)

  • 1. Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction.
    Greenspan NS; Cooper LJ
    Springer Semin Immunopathol; 1993; 15(2-3):275-91. PubMed ID: 8256202
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacterial carbohydrates in neonatal sepsis: targets for immunotherapy.
    Raff HV
    Springer Semin Immunopathol; 1993; 15(2-3):173-81. PubMed ID: 8256196
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1.
    Powers JH; Buster BL; Reist CJ; Martin E; Bridges M; Sutherland WM; Taylor RP; Scheld WM
    Infect Immun; 1995 Apr; 63(4):1329-35. PubMed ID: 7890390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective murine monoclonal antibodies to Cryptococcus neoformans.
    Mukherjee J; Scharff MD; Casadevall A
    Infect Immun; 1992 Nov; 60(11):4534-41. PubMed ID: 1398966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.
    Wolff EA; Schreiber GJ; Cosand WL; Raff HV
    Cancer Res; 1993 Jun; 53(11):2560-5. PubMed ID: 8495420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of IgM monoclonal antibodies in experimental group B streptococcal infection is a function of antibody avidity.
    Pincus SH; Shigeoka AO; Moe AA; Ewing LP; Hill HR
    J Immunol; 1988 Apr; 140(8):2779-85. PubMed ID: 2451694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1.
    Raff HV; Bradley C; Brady W; Donaldson K; Lipsich L; Maloney G; Shuford W; Walls M; Ward P; Wolff E
    J Infect Dis; 1991 Feb; 163(2):346-54. PubMed ID: 1988519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin.
    Bohnsack JF; Hawley MM; Pritchard DG; Egan ML; Shigeoka AO; Yang KD; Hill HR
    J Immunol; 1989 Nov; 143(10):3338-42. PubMed ID: 2681414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hybridoma immunoglobulin switch variants in the analysis of the protective properties of anti-lipopolysaccharide antibodies in Escherichia coli K1 infection.
    Pelkonen S; Pluschke G
    Immunology; 1989 Oct; 68(2):260-4. PubMed ID: 2680911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibody homodimers. Effect of valency on in vitro and in vivo antibacterial activity.
    Wolff EA; Esselstyn J; Maloney G; Raff HV
    J Immunol; 1992 Apr; 148(8):2469-74. PubMed ID: 1560202
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.